# Seqirus Vaccines Limited – FDA Inspection, Jun 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/094aeeba-88ac-49ef-9851-6bfea5ab7508
Source feed: FDA_Inspections

> FDA inspection 1101068 of Seqirus Vaccines Limited, June 28, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101068
- Company Name: Seqirus Vaccines Limited
- Inspection Date: 2019-06-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1278103 - 2025-06-10
- [FDA Inspection 1206283 - 2023-05-26](https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/5706e716-8e0d-474d-b006-75d777a6ef04)
- [FDA Inspection 1019950 - 2017-06-30](https://www.keypedia.com/records/fda_inspections/seqirus-vaccines-limited/c013bf07-0028-45f4-844d-94604c5839e2)
- FDA Inspection 932651 - 2015-06-11
- FDA Inspection 826556 - 2013-03-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)

Company: https://www.keypedia.com/companies/seqirus-vaccines-limited/6ad0915f-2ffc-46ca-be22-7620c05657c7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
